Information date: 21 November 2026 — On 5 June 2025 People’s Daily reported that Vice Premier Han Zheng met a US high-level second-track dialogue delegation, the kind of contact that shifts deal teams’ assumptions about the direction of bilateral commercial restrictions. In cross-border SPAs with China targets, US acquirers are re-papering the sanctions and export-control representations to cover Chinese countermeasures: whether the target or its affiliates appear on the unreliable entity list, whether any group company is subject to PRC counter-sanctions, and whether the target has supplied parties designated under US measures. The representations are being split, with separate schedules for US-facing and China-facing restrictions. If the target has any China-facing exposure, split the representation into separate US and PRC limbs with a closing-date bring-down and a specific indemnity. If screening returns a match on any affiliate, require pre-closing delisting or a purchase price adjustment before signing. If the exposure is purely hypothetical without any designated counterparty, keep the representation factual rather than knowledge-qualified and avoid over-scoping the indemnity.
Verified facts and scope
On 5 June 2025 People’s Daily reported that Vice Premier Han Zheng met a US high-level second-track dialogue delegation, the kind of contact that shifts deal teams’ assumptions about the direction of bilateral commercial restrictions. In cross-border SPAs with China targets, US acquirers are re-papering the sanctions and export-control representations to cover Chinese countermeasures: whether the target or its affiliates appear on the unreliable entity list, whether any group company is subject to PRC counter-sanctions, and whether the target has supplied parties designated under US measures. The representations are being split, with separate schedules for US-facing and China-facing restrictions.
Scope has to be fixed before the numbers mean anything: Applies to acquisitions of PRC targets by US or allied buyers, and to China outbound deals where the target has US nexus. Pre-work: screen the target and every affiliate against US, EU and UN sanctions lists and against the PRC unreliable entity list; review export-control classification of the target’s products; check for prior dealings with designated parties; and identify any licences the target holds that could be suspended. Confirm whether the SPA’s definition of sanctionable person now needs a China-specific limb. Anything outside that set is a separate question with its own evidence requirement, and mixing the two is the most common way a workable plan turns into an unusable one.
For a decision on “News: After Han Zheng Meets the US Second-Track Dialogue Delegation, China Deal Teams Re-Paper the Sanctions and Unreliable-Entity Representations in the SPA — What a US Acquirer Now Wants Before Signing”, keep three layers apart: the published rule or statistic, the company’s own orders and process records, and the assumptions nobody has tested yet. The first layer defines the external conditions, the second proves what is true for this business, and the third is where the risk actually sits. Public material cannot substitute for a contract, a system log, a sample or a live test.
A practical way to test the scope is to ask which parts of “News: After Han Zheng Meets the US Second-Track Dialogue Delegation, China Deal Teams Re-Paper the Sanctions and Unreliable-Entity Representations in the SPA — What a US Acquirer Now Wants Before Signing” would still be true if the company changed supplier, entity or product line tomorrow. Items that survive that change belong to the rule layer and can be taken from official publications; items that do not survive belong to the operating layer and have to be rebuilt from invoices, warehouse records, customs entries or platform statements. Where Applies to acquisitions of PRC targets by US or allied buyers, and to China outbound deals where the target has US nexus. Pre-work: screen the target and every affiliate against US, EU and UN sanctions lists and against the PRC unreliable entity list; review export-control classification of the target’s products; check for prior dealings with designated parties; and identify any licences the target holds that could be suspended. Confirm whether the SPA’s definition of sanctionable person now needs a China-specific limb, the two layers are frequently mistaken for each other, and an action plan built on the wrong one either over-complies or misses a deadline it never saw coming.
How the effect reaches operations
The two legal regimes are not symmetrical, so a single sanctions representation drafted for US law leaves a gap on the China side and vice versa. A US acquirer inheriting a target with unreliable-entity exposure faces both a US enforcement question and a PRC operational risk, since listing affects import, export and government procurement. Because the lists change quickly, representations drafted as of signing date go stale; closing-date and bring-down mechanics, plus specific indemnities, are replacing generic compliance covenants.
The frequent error is copying a template sanctions representation that covers only US and EU lists, leaving the unreliable entity list and PRC counter-sanctions unaddressed. A second is a bring-down that is too loose, letting the seller certify only knowledge rather than fact. A third is missing affiliate-level exposure, since listing often attaches to group entities rather than the contracting company, and a fourth is assuming regulatory approval risk is priced into the indemnity when the real cost is post-closing licence suspension.
Translated into an operating sequence, The two legal regimes are not symmetrical, so a single sanctions representation drafted for US law leaves a gap on the China side and vice versa. A US acquirer inheriting a target with unreliable-entity exposure faces both a US enforcement question and a PRC operational risk, since listing affects import, export and government procurement. Because the lists change quickly, representations drafted as of signing date go stale; closing-date and bring-down mechanics, plus specific indemnities, are replacing generic compliance covenants. That ordering matters: check applicability first, then the transmission step, and only then the size of the gap in cost or timing. When an intermediate step cannot be confirmed, the honest response is to narrow the scope of the conclusion rather than to substitute an industry average for the company’s own figures.
The cost of getting the order wrong is asymmetric. A team that checks applicability too late usually discovers it at the point where the shipment, the filing or the invoice can no longer be changed without penalty, and by then the only remaining lever is price. A team that checks early spends a few hours on questions that turn out to be irrelevant, which is cheap by comparison. On “News: After Han Zheng Meets the US Second-Track Dialogue Delegation, China Deal Teams Re-Paper the Sanctions and Unreliable-Entity Representations in the SPA — What a US Acquirer Now Wants Before Signing” the practical rule is therefore to spend the first hour on scope and the second on the numbers, never the other way round.
Decision
If the target has any China-facing exposure, split the representation into separate US and PRC limbs with a closing-date bring-down and a specific indemnity. If screening returns a match on any affiliate, require pre-closing delisting or a purchase price adjustment before signing. If the exposure is purely hypothetical without any designated counterparty, keep the representation factual rather than knowledge-qualified and avoid over-scoping the indemnity.
The conditions should be written down so the decision can be re-run by someone else: Applies to acquisitions of PRC targets by US or allied buyers, and to China outbound deals where the target has US nexus. Pre-work: screen the target and every affiliate against US, EU and UN sanctions lists and against the PRC unreliable entity list; review export-control classification of the target’s products; check for prior dealings with designated parties; and identify any licences the target holds that could be suspended. Confirm whether the SPA’s definition of sanctionable person now needs a China-specific limb. When those hold, proceed as described; when one is missing, close the gap first and decide afterwards. This is a deal-drafting note based on a published official report of a diplomatic meeting, not legal advice. Sanctions, export-control and unreliable-entity listing positions change frequently and must be verified against current official lists by qualified counsel in each jurisdiction.
Two workstreams usually have to move in parallel. The compliance workstream closes the document side of “News: After Han Zheng Meets the US Second-Track Dialogue Delegation, China Deal Teams Re-Paper the Sanctions and Unreliable-Entity Representations in the SPA — What a US Acquirer Now Wants Before Signing” — registrations, confirmations, filings — while the commercial workstream protects the delivery date, the pricing already quoted and the customer commitments that were made on the earlier reading of the rules. Running them as one queue is how small documentation gaps become missed shipment dates: the commercial side waits for a certificate that could have been requested a week earlier. If the target has any China-facing exposure, split the representation into separate US and PRC limbs with a closing-date bring-down and a specific indemnity. If screening returns a match on any affiliate, require pre-closing delisting or a purchase price adjustment before signing. If the exposure is purely hypothetical without any designated counterparty, keep the representation factual rather than knowledge-qualified and avoid over-scoping the indemnity. Set one owner per workstream and one shared status sheet, and treat a red item on either side as a reason to freeze only the affected order.
Implementation checklist
- Screen the target and every affiliate against US, EU and PRC lists separately.
- Split sanctions representations into US-facing and China-facing limbs with closing bring-downs.
- Attach a specific indemnity to any unreliable-entity or counter-sanctions exposure.
- Name one decision owner, one execution owner and one review date.
- Keep the source page, access date, entity and internal evidence.
- On any change, reopen only the affected judgement.
Evidence and review
Start with the smallest test that can change the answer: Screen the target and every affiliate against US, EU and PRC lists separately. Pick one real entity or one representative case, write down the continue, watch and stop conditions in advance, and record the input version, the owner, the start time and the actual result. The first pass should only look at facts that move the decision; formatting preferences are not risk.
The second pass is completed by “Split sanctions representations into US-facing and China-facing limbs with closing bring-downs”, and someone who did not prepare the file should spot-check one piece of critical evidence. The frequent error is copying a template sanctions representation that covers only US and EU lists, leaving the unreliable entity list and PRC counter-sanctions unaddressed. A second is a bring-down that is too loose, letting the seller certify only knowledge rather than fact. A third is missing affiliate-level exposure, since listing often attaches to group entities rather than the contracting company, and a fourth is assuming regulatory approval risk is priced into the indemnity when the real cost is post-closing licence suspension. A single small deviation can be corrected in place; a repeated deviation, or one that touches a statutory duty or changes the economics, is what justifies pausing the affected part.
After “Attach a specific indemnity to any unreliable-entity or counter-sanctions exposure”, compare the actual result with the baseline rather than with the impression of the team. If the target has any China-facing exposure, split the representation into separate US and PRC limbs with a closing-date bring-down and a specific indemnity. If screening returns a match on any affiliate, require pre-closing delisting or a purchase price adjustment before signing. If the exposure is purely hypothetical without any designated counterparty, keep the representation factual rather than knowledge-qualified and avoid over-scoping the indemnity. When the arrangement is extended to more products, customers or processes, keep the same success test and one complete record per batch. If later information changes, update only the affected fields.
One last discipline keeps the file usable next quarter: write the closing note as if a colleague who has never spoken to the supplier has to act on it. That note states what was verified, on which date, against which source, and what remains open — on “News: After Han Zheng Meets the US Second-Track Dialogue Delegation, China Deal Teams Re-Paper the Sanctions and Unreliable-Entity Representations in the SPA — What a US Acquirer Now Wants Before Signing” it also states which of the three actions was actually finished and which was only scheduled. Teams that skip the closing note re-litigate the same question every month, and each round costs more than the documentation would have. This is a deal-drafting note based on a published official report of a diplomatic meeting, not legal advice. Sanctions, export-control and unreliable-entity listing positions change frequently and must be verified against current official lists by qualified counsel in each jurisdiction.
Limits of the conclusion
This is a deal-drafting note based on a published official report of a diplomatic meeting, not legal advice. Sanctions, export-control and unreliable-entity listing positions change frequently and must be verified against current official lists by qualified counsel in each jurisdiction.
The limits are structural rather than cautious wording. Public sources describe rules and market conditions; they do not observe “News: After Han Zheng Meets the US Second-Track Dialogue Delegation, China Deal Teams Re-Paper the Sanctions and Unreliable-Entity Representations in the SPA — What a US Acquirer Now Wants Before Signing” inside a specific company. Where the analysis quotes a second-hand interpretation, the original release has to remain reachable, and a figure that cannot be traced back does not enter the decision table. Where the point depends on Applies to acquisitions of PRC targets by US or allied buyers, and to China outbound deals where the target has US nexus. Pre-work: screen the target and every affiliate against US, EU and UN sanctions lists and against the PRC unreliable entity list; review export-control classification of the target’s products; check for prior dealings with designated parties; and identify any licences the target holds that could be suspended. Confirm whether the SPA’s definition of sanctionable person now needs a China-specific limb, the conclusion is only as current as the last check of those conditions.
